09:58 AM EDT, 07/01/2024 (MT Newswires) -- The Federal Trade Commission has opened an investigation into Teva Pharmaceutical Industries ( TEVA ) over the company's alleged refusal to remove roughly 24 patents for its asthma and chronic obstructive pulmonary disease inhalers, The Washington Post reported Monday, citing confidential agency documents it viewed.

Neither the FTC nor Teva responded immediately to MT Newswires' requests for comment.

Shares of Teva fell 1.9% in recent trading.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 15.95, Change: -0.30, Percent Change: -1.85